Literature DB >> 17301260

Diabetes and risk of endometrial cancer: a population-based prospective cohort study.

Emilie Friberg1, Christos S Mantzoros, Alicja Wolk.   

Abstract

Although there is accumulating evidence that hyperinsulinemia in the context of insulin resistance is associated with carcinogenesis, only one prospective study of endometrial cancer incidence, in relation to diabetes, addressed this issue and showed no significant positive association. No previous study has investigated whether physical activity can modify the association between diabetes and endometrial cancer. We examined the association between diabetes and incidence of endometrial cancer and the potential effect modification by obesity and physical activity in the Swedish Mammography Cohort, a prospective cohort of 36,773 women, including 225 incident endometrial adenocarcinoma cases. After adjustments, the relative risk (RR) for endometrial cancer among women with diabetes comparing with nondiabetic women was 1.94 [95% confidence interval (95% CI), 1.23-3.08]. Among obese diabetics, the RR was 6.39 (95% CI, 3.28-12.06) compared with nonobese nondiabetic women. Among diabetics with low physical activity, the RR for endometrial cancer was 2.80 (95% CI, 1.62-4.85) compared with physically active nondiabetic women. Obese diabetics with low physical activity had a RR of 9.61 (95% CI, 4.66-19.83) compared with normal weight nondiabetic women with high physical activity. Diabetes was associated with a 2-fold increased risk, and combination of diabetes with obesity and low physical activity was associated with a further increased risk for endometrial cancer. Interventions to reduce body weight and increase physical activity may have important implications in terms of prevention of endometrial cancer and future management of diabetic subjects.

Entities:  

Mesh:

Year:  2007        PMID: 17301260     DOI: 10.1158/1055-9965.EPI-06-0751

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  54 in total

1.  Response to an exercise intervention after endometrial cancer: differences between obese and non-obese survivors.

Authors:  K Basen-Engquist; C Carmack; J Brown; A Jhingran; G Baum; J Song; S Scruggs; M C Swartz; M G Cox; K H Lu
Journal:  Gynecol Oncol       Date:  2014-04       Impact factor: 5.482

2.  Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma.

Authors:  Adrienne S McCampbell; Heather A Harris; Judy S Crabtree; Richard C Winneker; Cheryl L Walker; Russell R Broaddus
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-23

3.  Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study.

Authors:  Pamela T Soliman; Qian Zhang; Russell R Broaddus; Shannon N Westin; David Iglesias; Mark F Munsell; Rosemarie Schmandt; Melinda Yates; Lois Ramondetta; Karen H Lu
Journal:  Gynecol Oncol       Date:  2016-10-13       Impact factor: 5.482

4.  Serum glucose and hemoglobin A1C levels at cancer diagnosis and disease outcome.

Authors:  Ben Boursi; Bruce J Giantonio; James D Lewis; Kevin Haynes; Ronac Mamtani; Yu-Xiao Yang
Journal:  Eur J Cancer       Date:  2016-03-25       Impact factor: 9.162

5.  Association Between Single Nucleotide Polymorphism +276G > T (rs1501299) in ADIPOQ and Endometrial Cancer.

Authors:  Jan Bieńkiewicz; Beata Smolarz; Andrzej Malinowski
Journal:  Pathol Oncol Res       Date:  2015-09-19       Impact factor: 3.201

6.  Diabetes mellitus and risk of endometrial cancer: a meta-analysis.

Authors:  E Friberg; N Orsini; C S Mantzoros; A Wolk
Journal:  Diabetologia       Date:  2007-05-03       Impact factor: 10.122

7.  Relationships of uterine and ovarian tumors to pre-existing chronic conditions.

Authors:  Louise A Brinton; Lori C Sakoda; Kirsten Frederiksen; Mark E Sherman; Susanne K Kjaer; Barry I Graubard; Jorgen H Olsen; Lene Mellemkjaer
Journal:  Gynecol Oncol       Date:  2007-09-07       Impact factor: 5.482

8.  Enhanced estrogen-induced proliferation in obese rat endometrium.

Authors:  Qian Zhang; Qi Shen; Joseph Celestino; Michael R Milam; Shannon N Westin; Robin A Lacour; Larissa A Meyer; Gregory L Shipley; Peter J A Davies; Lei Deng; Adrienne S McCampbell; Russell R Broaddus; Karen H Lu
Journal:  Am J Obstet Gynecol       Date:  2009-02       Impact factor: 8.661

9.  Predicting the risk of endometrial cancer in postmenopausal women presenting with vaginal bleeding: the Norwich DEFAB risk assessment tool.

Authors:  N Burbos; P Musonda; I Giarenis; A M Shiner; P Giamougiannis; E P Morris; J J Nieto
Journal:  Br J Cancer       Date:  2010-03-30       Impact factor: 7.640

10.  An association between anti-platelet drug use and reduced cancer prevalence in diabetic patients: results from the Vermont Diabetes Information System Study.

Authors:  Chris E Holmes; Maria E Ramos-Nino; Benjamin Littenberg
Journal:  BMC Cancer       Date:  2010-06-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.